SCR-LIP-000216 · Claim · machine-readable JSON →

A 305-gene NGS panel applied to 162 lipedema patients identified 21 heterozygous deleterious variants in 17 patients (10.5%) across 12 genes (PLIN1, LIPE, PPARG, POMC, NR0B2, GCKR, NPC1, ALDH18A1, GHR, INSR, RYR1, PPARA), most involved in steroidogenesis, lipid homeostasis, and insulin signaling, including PLIN1 c.722T>C linked to familial partial lipodystrophy type 4.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
2 source(s)
Dates
2026-05-31 → 2026-06-12

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

20222025A Multi-Gene Panel to Identify Lipedema-Predisposing Genetic Variants by a Next-Generation Sequencing Strategy — Michelini et al. (2022) · consistentLipedema: Progress, Challenges, and the Road Ahead — Cifarelli (2025) · consistent

Evidence (2)

Context (PECO)

Populationlipedema patients (n=162)
Conditionlipedema
Exposure305-gene NGS panel sequencing
Outcomeheterozygous deleterious variants in 12 genes
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log